Spyre (SYRE) Clears Monotherapy Phase for IBD Portfolio, Setting Up Combination Tests
finance.yahoo.com
17.09.2026 09:04
25 views
Related stories
Australian data centre operator pulls $5bn IPO
ft.com · 09.10
SpaceX’s Starlink Mobile plans are pressuring AT&T and Verizon shares
marketwatch.com · 09.10
Mark Zuckerberg has an image problem - so why is Meta's business booming?
bbc.co.uk · 09.10
Why are more roofs not made of solar tiles?
bbc.co.uk · 09.10
'Add me to WhatsApp' scam calls to be investigated
bbc.co.uk · 09.10
US to publicly execute former soldier by firing squad
ft.com · 09.10